SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-040318
Filing Date
2023-11-13
Accepted
2023-11-13 07:35:13
Documents
14
Period of Report
2023-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 38287
2 ex99-1.htm EX-99.1 65032
3 ex99-1_001.jpg GRAPHIC 3952
  Complete submission text file 0001493152-23-040318.txt   291808

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE abeo-20231113.xsd EX-101.SCH 3045
5 XBRL LABEL FILE abeo-20231113_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE abeo-20231113_pre.xml EX-101.PRE 22379
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3309
Mailing Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103
Business Address 6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OH 44103 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 231395128
SIC: 2834 Pharmaceutical Preparations